Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Droxidopa
Medication labelDroxidopa capsules indicated for the treatment of orthostatic dizziness, lightheadedness, or the “feeling that you are about to black out”…
Why this: Advisory · dailymed-prescription
Droxidopa capsules indicated for the treatment of orthostatic dizziness, lightheadedness, or the “feeling that you are about to black out” in adult patients with symptomatic neurogenic orthostatic hypotension (nOH) caused by primary autonomic failure (Parkinson's disease [PD], multiple system atrophy, and pure autonomic failure), dopamine beta-hydroxylase deficiency, and non-diabetic autonomic neuropathy. Effectiveness beyond 2 weeks of treatment has not been established. The continued effectiveness of droxidopa capsules should be assessed periodically.
- generic_name
- droxidopa
- product_names
- droxidopa
- ndc
- 70436-140, 70436-141, 70436-142, 70436-140-06, 70436-141-06, 70436-142-06
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en